{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:12:45Z","timestamp":1771546365200,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.xphs.2019.08.018","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:15:31Z","timestamp":1566904531000},"page":"422-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit"],"prefix":"10.1016","volume":"109","author":[{"given":"Kaimeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Hershey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2019.08.018_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"6230","key":"10.1016\/j.xphs.2019.08.018_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xphs.2019.08.018_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.12688\/f1000research.9970.1","article-title":"Recent advances in (therapeutic protein) drug development","volume":"6","author":"Lagass\u00e9","year":"2017","journal-title":"F1000Res"},{"issue":"7","key":"10.1016\/j.xphs.2019.08.018_bib4","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/jps.21180","article-title":"Heterogeneity of monoclonal antibodies","volume":"97","author":"Liu","year":"2008","journal-title":"J\u00a0Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2019.08.018_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1471-4906(01)01976-7","article-title":"Post-translational protein modifications in antigen recognition and autoimmunity","volume":"22","author":"Doyle","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.xphs.2019.08.018_bib6","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nbt1252","article-title":"Post-translational modifications in the context of therapeutic proteins","volume":"24","author":"Walsh","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2019.08.018_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12033-008-9049-4","article-title":"Post-translational modifications of recombinant proteins: significance for biopharmaceuticals","volume":"39","author":"Jenkins","year":"2008","journal-title":"Mol Biotechnol"},{"issue":"6","key":"10.1016\/j.xphs.2019.08.018_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1021\/bi951526c","article-title":"Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE:\u2009 identification and effect on binding affinity","volume":"35","author":"Cacia","year":"1996","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.xphs.2019.08.018_bib9","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/bi7018223","article-title":"Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin \u03b32 antibody highlights the role avidity plays in antibody activity","volume":"47","author":"Rehder","year":"2008","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.xphs.2019.08.018_bib10","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/acs.analchem.5b02800","article-title":"Isomerization and oxidation in the complementarity-determining regions of a monoclonal antibody: a study of the modification\u2013structure\u2013function correlations by hydrogen\u2013deuterium exchange mass spectrometry","volume":"88","author":"Yan","year":"2016","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.xphs.2019.08.018_bib11","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1021\/bi061500t","article-title":"Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies","volume":"46","author":"Wakankar","year":"2007","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.xphs.2019.08.018_bib12","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/jps.21655","article-title":"Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain","volume":"98","author":"Yan","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"43","key":"10.1016\/j.xphs.2019.08.018_bib13","doi-asserted-by":"crossref","first-page":"32676","DOI":"10.1074\/jbc.M604847200","article-title":"Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity","volume":"281","author":"Doyle","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.xphs.2019.08.018_bib14","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.4049\/jimmunol.177.7.4541","article-title":"Intracellular protein modification associated with altered T cell functions in autoimmunity","volume":"177","author":"Yang","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.xphs.2019.08.018_bib15","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/S0021-9258(18)83327-0","article-title":"Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins","volume":"264","author":"Stephenson","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.xphs.2019.08.018_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1399-3011.1987.tb03390.x","article-title":"Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins","volume":"30","author":"Clarke","year":"1987","journal-title":"Int J Pept Protein Res"},{"issue":"3","key":"10.1016\/j.xphs.2019.08.018_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.98.3.944","article-title":"Molecular clocks","volume":"98","author":"Robinson","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.xphs.2019.08.018_bib18","doi-asserted-by":"crossref","first-page":"e100736","DOI":"10.1371\/journal.pone.0100736","article-title":"Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions","volume":"9","author":"Sydow","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.xphs.2019.08.018_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0021-9258(19)75855-4","article-title":"Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation","volume":"262","author":"Geiger","year":"1987","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2019.08.018_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/bit.22561","article-title":"Isomerization in the CDR2 of a monoclonal antibody: binding analysis and factors that influence the isomerization rate","volume":"105","author":"Dick","year":"2010","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"10.1016\/j.xphs.2019.08.018_bib21","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/jps.20740","article-title":"Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization","volume":"95","author":"Wakankar","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2019.08.018_bib22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11095-007-9241-4","article-title":"Accumulation of succinimide in a recombinant monoclonal antibody in Mildly acidic buffers under elevated temperatures","volume":"24","author":"Chu","year":"2007","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2019.08.018_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(00)00548-X","article-title":"Identification of multiple sources of charge heterogeneity in a recombinant antibody","volume":"752","author":"Harris","year":"2001","journal-title":"J\u00a0Chromatogr B Biomed Sci Appl"},{"issue":"7","key":"10.1016\/j.xphs.2019.08.018_bib24","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/jps.20823","article-title":"The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody","volume":"96","author":"Wakankar","year":"2007","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2019.08.018_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1208\/s12248-017-0168-3","article-title":"A\u00a0view on the importance of \u201cMulti-Attribute method\u201d for measuring purity of biopharmaceuticals and improving overall control strategy","volume":"20","author":"Rogers","year":"2017","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.xphs.2019.08.018_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/19420862.2015.1069454","article-title":"Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics","volume":"7","author":"Rogers","year":"2015","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.xphs.2019.08.018_bib27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1080\/19420862.2017.1364326","article-title":"A\u00a0Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins","volume":"9","author":"Xu","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.xphs.2019.08.018_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/rcm.8301","article-title":"Subunit mass analysis for monitoring multiple attributes of monoclonal antibodies","volume":"33","author":"Liu","year":"2018","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"10.1016\/j.xphs.2019.08.018_bib29","first-page":"361","article-title":"Forced degradation study of monoclonal antibody using two- dimensional liquid chromatography","volume":"8","author":"Yan","year":"2017","journal-title":"J\u00a0Chromatogr Separation Tech"},{"issue":"1","key":"10.1016\/j.xphs.2019.08.018_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.analchem.6b03506","article-title":"Two-dimensional liquid chromatography: a state of the art tutorial","volume":"89","author":"Stoll","year":"2017","journal-title":"Anal Chem"},{"issue":"16","key":"10.1016\/j.xphs.2019.08.018_bib31","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1021\/acs.analchem.5b01578","article-title":"Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive two-dimensional liquid chromatography\u2013mass spectrometry","volume":"87","author":"Stoll","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2019.08.018_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2016.05.029","article-title":"Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection","volume":"1032","author":"Stoll","year":"2016","journal-title":"J\u00a0Chromatogr B"},{"issue":"Supplement C","key":"10.1016\/j.xphs.2019.08.018_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpba.2015.02.037","article-title":"Ion-exchange chromatography for the characterization of biopharmaceuticals","volume":"113","author":"Fekete","year":"2015","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"9","key":"10.1016\/j.xphs.2019.08.018_bib34","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1021\/ac702245c","article-title":"Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry","volume":"80","author":"Valliere-Douglass","year":"2008","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.xphs.2019.08.018_bib35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4161\/mabs.28693","article-title":"Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications","volume":"6","author":"Haverick","year":"2014","journal-title":"mAbs"},{"issue":"2","key":"10.1016\/j.xphs.2019.08.018_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ab.2011.04.030","article-title":"Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry","volume":"415","author":"Chevreux","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1016\/j.xphs.2019.08.018_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphar.2014.00087","article-title":"Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies","volume":"5","author":"Eakin","year":"2014","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2019.08.018_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mas.20190","article-title":"Mass spectrometry for structural characterization of therapeutic antibodies","volume":"28","author":"Zhang","year":"2009","journal-title":"Mass Spectrom Rev"},{"issue":"2","key":"10.1016\/j.xphs.2019.08.018_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/ac3032355","article-title":"Characterization of therapeutic antibodies and related products","volume":"85","author":"Beck","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2019.08.018_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ab.2018.11.021","article-title":"Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography","volume":"566","author":"Cao","year":"2019","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2019.08.018_bib41","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1021\/ac802708s","article-title":"Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion","volume":"81","author":"Huang","year":"2009","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2019.08.018_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2017.03.005","article-title":"Characterization of succinimide stability during trypsin digestion for LC-MS analysis","volume":"526","author":"Nowak","year":"2017","journal-title":"Anal Biochem"},{"key":"10.1016\/j.xphs.2019.08.018_bib43","doi-asserted-by":"crossref","first-page":"12798","DOI":"10.1038\/ncomms12798","article-title":"Unexpected functional implication of a stable succinimide in the structural stability of Methanocaldococcus jannaschii glutaminase","volume":"7","author":"Kumar","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.xphs.2019.08.018_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ab.2009.05.018","article-title":"An improved trypsin digestion method minimizes digestion-induced modifications on proteins","volume":"392","author":"Ren","year":"2009","journal-title":"Anal Biochem"},{"issue":"Supplement C","key":"10.1016\/j.xphs.2019.08.018_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chroma.2016.06.085","article-title":"High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation","volume":"1460","author":"Li","year":"2016","journal-title":"J\u00a0Chromatogr A"},{"issue":"6","key":"10.1016\/j.xphs.2019.08.018_bib46","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0731-7085(99)00181-8","article-title":"Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times?","volume":"21","author":"Bongers","year":"2000","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"18","key":"10.1016\/j.xphs.2019.08.018_bib47","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1021\/ac050672d","article-title":"Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies","volume":"77","author":"Chelius","year":"2005","journal-title":"Anal Chem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919305192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919305192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:31:45Z","timestamp":1758360705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919305192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0022354919305192"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.08.018","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}